Recorded fact · drug.label_indication
drug.label_indication for enzalutamide|prostate-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 696605c8 resolves to.
The record
| Fact id | 696605c88ddb3f5d0e6d529a |
|---|---|
| Entity | drug: enzalutamide|prostate-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260728 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
castration-resistant prostate cancer (CRPC) • metastatic castration-sensitive prostate cancer (mCSPC) • non‑metastatic castration‑sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis
Shown with dashes as hyphens. SHA-256 of the exact stored quote: d11f9a6efcdc570a991b030011efe9a982cd22eb2978c00999e9842474243762.
The value
{
"ingredient": "ENZALUTAMIDE",
"conditionId": "prostate-cancer",
"conditionName": "Prostate Cancer",
"matchedAlias": "prostate cancer",
"context": "indication",
"brand": "Xtandi",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf",
"labelEffectiveTime": "20260728",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 35958b0ae47df4a011d13c6a16a809a20a000b9ed7916fa2a6224ad92cdc509c.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.